Table 5.
Gene | Identifier | Log 2 fold change | p Value | References |
---|---|---|---|---|
Fmr1 | FBgn0028734 | −0.874096 | 0.028043* | 1 |
lig | FBgn0020279 | −1.006 | 0.032011* | 2 |
14-3-3zeta | FBgn0004907 | −0.250421 | 0.023824* | 3 |
Ank2 | FBgn0261788 | −0.1607 | 0.040059* | 4 |
CG4612 | FBgn0035016 | −0.324925 | 0.011309* | 5 |
SLC22A | FBgn0037140 | −0.850807 | 0.006731* | 6 |
Fdh | FBgn0011768 | 0.29288 | 0.007593* | 7 |
Pka-C1 | FBgn0000273 | −0.229651 | 0.009899* | 8 |
Pka-R1 | FBgn0259243 | −0.217834 | 0.006967* | 9 |
Sap47 | FBgn0013334 | −0.802852 | 0.003545* | 10 |
Syn | FBgn0004575 | −0.150291 | 0.005463* | 11 |
Selected proteins, p value, and average log2 fold differences (four biological and three technical replicas) have been calculated as described in Materials and Methods. Control animals are Elav-Gal4;TubGal80ts >+ vs Elav-Gal4;TubGal80ts >dtauRNAi induced for 3 d at 30°C. The log2 fold change becomes positive when RNAi > control and negative when control > RNAi. The t test was performed with a permutation-based FDR (0.05) calculation, and the p value determines the statistical significance (*p < 0.05). In bold are proteins whose levels were also found to be changed in the mutant (Table 3). References: 1, Kanellopoulos et al. (2012); 2, Walkinshaw et al. (2015); 3, Philip et al. (2001); 4, Iqbal et al. (2013); 5, Khan et al. (2015); 6, Gai et al. (2016); 7, Hou et al. (2011); 8, Horiuchi et al. (2008); 9, Goodwin et al. (1997); 10, Saumweber et al. (2011); and 11, Godenschwege et al. (2004).